Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Risks for chronic kidney disease progression, CV events lower with finerenone versus placebo
Read More »ASN: Finerenone May Slow Progression in CKD With T2DM
Green Tea, Coffee Intake Linked to Reduced Mortality in T2DM
Higher levels of consumption of green tea and/or coffee may reduce mortality in those with T2DM
Read More »Maternal Hypothyroidism Linked to Risk for ADHD in Offspring
Risk for ADHD increased in children of mothers with hypothyroidism diagnosed prior to, during pregnancy
Read More »Outcomes Worse for Women With MI at 50 Years or Younger
Women less likely to undergo coronary revascularization, receive guideline-directed medical treatment
Read More »Ertugliflozin Noninferior for CV Outcomes in T2DM With ASCVD
Ertugliflozin is noninferior to placebo for the primary end point of major adverse cardiovascular events
Read More »Sitagliptin May Cut Mortality in T2DM Patients With COVID-19
Sitagliptin at time of hospitalization linked to reduced mortality, improved clinical outcomes
Read More »FDA Warns Companies About Illegal Sales of Dietary Supplements
The supplements contain cesium chloride, but no cesium chloride-containing products are FDA-approved
Read More »T2DM Links to Risk for Dementia Differ by Type, Glycemic Control
Dose-response association shows higher risk for dementia with HbA1c >87 versus <52 mmol/mol
Read More »Manufacturer Prices for Insulin Substantially Higher in the U.S.
Manufacturer prices more than eight times higher in the U.S. than in other high-income countries
Read More »DKA Episode May Harm Cognitive Function in Children With T1D
Lower IQ and worse memory seen in children with newly diagnosed type 1 diabetes and single event
Read More »